{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"NKGen Biotech, Inc."},"Symbol":{"label":"Symbol","value":"NKGNW"},"Address":{"label":"Address","value":"3001 DAIMLER STREET, SANTA ANA, California, 92705, United States"},"Phone":{"label":"Phone","value":"949 396 6830"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform.Ã‚ Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system."},"CompanyUrl":{"label":"Company Url","value":"https://www.nkgenbiotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Paul Y. Song","title":"Chairman & Chief Executive Officer"},{"name":"Yong Man Kim","title":"Director & Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}